Ningetinib
- Generic Name
- Ningetinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C31H29FN4O5
- CAS Number
- 1394820-69-9
- Unique Ingredient Identifier
- PW3Q92Z6A4
- Background
Ningetinib is under investigation in clinical trial NCT03758287 (Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative).
- Associated Conditions
- -
- Associated Therapies
- -
KN046 in Patients With Advanced Non-small Cell Lung Cancer
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2019-02-12
- Last Posted Date
- 2023-03-02
- Lead Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Target Recruit Count
- 120
- Registration Number
- NCT03838848
- Locations
- 🇨🇳
Shanghai Pulmonary Hospital, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath